Kelly Romano

Track

Insider profile

Currently holds positions in Dorman Products Inc and UGI Corp

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Dorman Products Inc Nov. 9, 2017 -
Independent Director UGI Corp Jan. 1, 2019 -
Kelly Romano's trades of LeonaBio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US LeonaBio Inc (ATHA)
Transaction date
Purchase
Price
257.17
Quantity 44,844 +44.6%
Value US$994,247
US LeonaBio Inc (ATHA)
Transaction date
Purchase
Price
119.77
Quantity 3,584 +2.5%
Value US$4,872,350
US LeonaBio Inc (ATHA)
Transaction date
Purchase
Price
241.50
Quantity 9,361 -10.8%
Value US$2,546,127
US LeonaBio Inc (ATHA)
Transaction date
Purchase
Price
13.11
Quantity 8,000 +2539.7%
Value US$104,880
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-25 2024-06-24
US LeonaBio Inc (ATHA)
B Purchase
44,844 +44.6%
257.17
US$994,247 		44,844 +44.6% 257.17 US$994,247
2024-06-25 2024-06-21
US LeonaBio Inc (ATHA)
B Purchase
3,584 +2.5%
119.77
US$4,872,350 		3,584 +2.5% 119.77 US$4,872,350
2022-12-06 2022-12-02
US LeonaBio Inc (ATHA)
B Purchase
9,361 -10.8%
241.50
US$2,546,127 		9,361 -10.8% 241.50 US$2,546,127
2022-04-01 2022-03-31
US LeonaBio Inc (ATHA)
B Purchase
8,000 +2539.7%
13.11
US$104,880 		8,000 +2539.7% 13.11 US$104,880